Catheter-related Blood Stream Infection in a Patient with Hemodialysis by Dharmayanti, Anti & Astrawinata, Dalima
CASE  REPORT
244 Acta Med Indones - Indones J Intern Med • Vol 50 • Number 3 • July 2018 
Catheter-related Blood Stream Infection in a Patient with 
Hemodialysis
Anti Dharmayanti1, Dalima Astrawinata2
1 Department of Clinical Pathology, Fatmawati Central General Hospital, Jakarta, Indonesia.
2 Department of Clinical Pathology, Faculty of Medicine Universitas Indonesia - Cipto Mangunkusumo Hospital, 
Jakarta, Indonesia.
Corresponding Author:
Anti Dharmayanti, MD. Department of Clinical Pathology, Fatmawati Central General Hospital. Jl. RS Fatmawati, 
Cilandak, Jakarta 12430, Indonesia. email: antidharmayanti@yahoo.com.
ABSTRAK
Seorang pasien pria usia 31 tahun, datang berobat jalan ke rumah sakit untuk hemodialisis (HD) rutin 2 
kali dalam seminggu. Saat dilakukan tindakan HD mendadak pasien demam dan menggigil, saat itu ditegakkan 
diagnosis catheter-related blood stream infection (CR-BSI), dilakukan pencabutan catheter double lumen 
(CDL) dan pasien kemudian dirawat. Hasil kultur tip CDL dan kultur darah perifer didapatkan kuman yang 
sama yaitu Enterobacter cloacae. Diagnosis CR-BSI pada kasus ini ditegakkan berdasarkan kriteria Infectious 
Disease Society of America (IDSA) tahun 2009. Secara keseluruhan harus diperhatikan langkah pencegahan 
CR-BSI berupa edukasi pasien dan petugas yang memasang CDL, penerapan prosedur tindakan aseptik kulit 
yang benar serta perawatan exit site CDL, untuk mencegah terjadinya CR-BSI.
Kata kunci: catheter-related blood stream infection (CR-BSI), Infectious Disease Society of America (IDSA), 
catheter double lumen (CDL).
ABSTRACT
A 31-year-old patient came to visit the outpatient clinic at the hospital for his routine twice-weekly hemodialyis 
(HD) session. During HD, the patient suddenly developed a fever with shivering. At that time, a diagnosis of 
catheter-related blood stream infection (CR-BSI) was developed, HD catheter or the catheter double lumen 
(CDL) was uninstalled and the patient was hospitalized. Results of culture withdrawn through the tip of catheter 
lumen and peripheral blood revealed identical microorganism, i.e. the Enterobacter cloacae. Diagnosis of CR-
BSI in the present case was made based on the 2009 Infectious Disease Society of America (IDSA) criteria. 
In general, prevention measures for CR-BSI should be taken into account including education for patient, 
awareness of the health care providers who install the CDL, implementation of procedure for appropriate skin 
aseptic technique and best practice for HD catheter care, particularly on the exit site of the CDL to prevent the 
development of CR-BSI.
Keywords: catheter-related blood stream infection (CR-BSI), Infectious Disease Society of America (IDSA) 
criteria, catheter double lumen (CDL).
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INTRODUCTION
Bacteremia or the presence of bacteria in 
the bloodstream may occur in patients who 
are undergoing hemodialysis (HD) treatment 
and generally the source of infection includes 
cannula or catheter double lumen (CDL).1 
Catheter-Related Blood Stream Infection (CR-
BSI) is defined when the results of cultures 
show that microorganism isolated from catheter 
tips and peripheral blood cultures are identical 
without another source of infection other than 
the catheter/CDL itself in HD patients with 
symptoms of systemic infection.1-3 The term 
CR-BSI is determined based on accurate data 
of laboratory results, which identify CDL as 
the source of infection in the bloodstream. The 
term is usually used to establish diagnosis, 
provide treatment and study the epidemiology 
of bloodstream infection in patients who 
undergo CDL insertion.4,5 In order to establish 
the diagnosis of CR-BSI, laboratory data are 
necessary, which include data of paired culture 
obtained from CVC/CDL tips and peripheral 
blood.2-4
Catheter Related Blood stream Infection 
(CR-BSI) is a part of the primary bloodstream 
infection (PBI) or laboratory confirmed 
bloodstream infection, in which there is an 
infection in the bloodstream that occurs without 
any suspected organ or other tissue as the source 
of infection. The risk factors are susceptibility to 
infection and intravenous (IV) catheter insertion, 
which is associated with type of cannula, 
insertion method and duration of cannula 
insertion.6 Catheter insertion for HD can be done 
permanently or temporarily, i.e. several months 
prior to the permanent insertion.5,7 Whenever 
the permanent insertion has not been possible, 
the use of temporary insertion can be extended.7 
Permanent catheter insertion is usually 
carried out by performing surgical procedure of 
creating arteriovenous fistula (A-V fistula). The 
A-V fistula requires 2 to 8 weeks for recovery 
and maturation before it is ready and to serve 
a useful function for HD procedure; therefore, 
temporary CDL insertion can be useful as an 
alternative, particularly in emergency setting.5
Temporary insertion of CDL is a catheter 
placement using vascular access through 
peripheral veins or large intrathoracic veins 
such as subclavian, internal jugular or femoral 
veins, which ends at the superior cava vein 
or right atrium. It serves a useful function 
in measuring central venous pressure or 
inserting hyperosmolar intravenous fluid during 
hemodialysis procedure.4,5 There are 4 types of 
CDL insertion based on technique and duration 
of catheter insertion, which are non-tunneled 
CDL, tunneled CDL, peripherally inserted 
central catheters (PICCS) and implanted ports.4
CASE ILUSTRATION
Mr. A, a 31-year-old, came to outpatient 
clinic of HD in Fatmawati Hospital for his 
routine twice-weekly hemodialyis (HD) session. 
The patient had undergone HD within the last 
2 months at Fatmawati Hospital and he had 
CDL insertion since the routine HD session was 
performed. He was on waiting list for having the 
Cimino arteriovenous shunt Cimino insertion in 
an operating room. During the HD procedure 
(± 4 hours after the HD had been initiated), the 
patient developed a fever with shivering and 
his doctor instructed to stop hemodyalisis and 
recommended the patient to be hospitalized. 
There was no history of fever during the 
previous routine HD sessions. History of having 
hypertension, urolithiasis or diabetes was denied. 
The patient worked as a casual laborer with an 
education level of junior high school.
His physical examination revealed that his 
qualitative awareness level was compos mentis 
(fully alert) with blood pressure of 140/90 
mmHg, pulse rate of 110 beats per minute, 
respiratory rate of 22 beats per minute, body 
temperature of 380C and normal body mass 
index (BMI = 21.48). On his neck, a CDL was 
inserted on the right internal jugular vein and 
there was redness around the exit site of the 
catheter with no purulent discharge. There were 
no abnormal findings of his chest, abdomen and 
extremities. The chest radiography showed that 
the heart and lungs were within normal limits. 
A diagnosis of chronic kidney disease (CKD) 
on HD + suspected catheter-related bloodstream 
infection (CR-BSI) was made. The CDL was 
then removed and the patient received following 
treatment, i.e. intravenous fluid drip of ringer 
245
Anti Dharmayanti                                                                                                            Acta Med Indones-Indones J Intern Med
lactate (RL) at 10 drips/minute; ceftriaxone at 
the dose of 2 x 1 gram by intravenous route and 
3 x 500 mg paracetamol by oral route. Isolation 
of microorganisms, cultures and antimicrobial 
resistance testing were performed. Cultures were 
carried out with samples obtained from CDL tip 
and blood withdrawn from the left cubital veins. 
The result of blood test revealed anemia with 
Hb levels of 9.9 g/dL (normal limit: 13.2-17.3 
g/dL), neutrophilia with neutrophil counts of 
12,000/uL (normal limit: 5000-10000/uL); while 
the ALT, AST, total protein and blood glucose 
levels were within the normal limits. There was 
high ureum level of 126 mg/dL (normal limit: 
20-40 mg/dL) and the creatinine level was also 
high with 7.4 mg/dL (normal limit: 0.6-1.5 mg/
dL). The estimated creatinine clearance based 
on the Chronic Kidney Disease Epidemiology 
Collaboration (CKD-EPI) equation was 9. 
Results of cultures through CDL tips and blood 
cultures as well as the antimicrobial resistance 
testing can be seen in Table 1.
Results of culture withdrawn through the 
tip of catheter lumen and peripheral blood 
revealed identical microorganism, i.e. the 
Enterobacter cloacae, which is one of Multiple 
Drug Resistant Organisms (MDRO) and the 
results of antimicrobial resistance testing were 
also identical for both cultures.
Empirical treatment using ceftriaxone was 
administered for 3 days and after the results of 
culture were received, a definitive treatment 
using meropenem for 3 days was provided, which 
was adjusted to the culture results. The patient 
was discharged from hospital with improvement. 
DISCUSSION
Our patient is a 31-year-old male who 
came to outpatient clinic of HD in Fatmawati 
Hospital with a diagnosis of CKD + suspected 
CR-BSI. The whole blood count revealed 
normocytic normochromic anemia, neutrophilia 
as well as increased ureum and creatinine 
level, which supported a diagnosis of CKD. 
In this case, we found that the estimated 
creatinine clearance based on the Chronic Kidney 
Disease Epidemiology Collaboration (CKD-
EPI) equation was 9, which is appropriate to 
the diagnosis of kidney failure or stage 5 CKD 
according to the 2012 KDIGO criteria and HD 
procedure is required. The neutrophilia indicated 
that there was an inflammatory process or an 
infection in the patient. Samples for culture and 
antimicrobial resistance testing from the CDL tip 
and blood were sent and at the same time, CDL 
was removed and sent for further evaluation. 
Results of culture withdrawn through the tip of 
catheter lumen and peripheral blood revealed 
Table 1. Results of culture and antimicrobial resistance testing with samples obtaind from CDL tip
Isolates: Enterobacter cloacae
 - Amoxycillin clavulanic acid  R Amikacin S
 - Cefuroxime  R Gentamicin S
 - Ceftazidime  R Ciprofloxacin R
 - Cefotaxime  R Levofloxacin I
 - Ceftriaxone  R Cotrimoxazole R
 - Cefepime  R Chloramphenicol R
 - Meropenem  S Fosfomycin R
Results of blood culture
 - Amoxycillin clavulanic acid R Amikacin S
 - Cefuroxime R Gentamicin S
 - Ceftazidime R Ciprofloxacin R
 - Cefotaxime R Levofloxacin I
 - Ceftriaxone R Cotrimoxazole R
 - Cefepime R Chloramphenicol R
 - Meropenem S Fosfomycin R
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identical microorganism, i.e. the Enterobacter 
cloacaeand the results of antimicrobial resistance 
testing were also identical for both cultures that 
the patient was still sensitive to the following 
antibiotics, i.e. meropenem, amikasin and 
gentamicin.
There are some methods for laboratory 
culture evaluation with samples obtained 
from the catheter tip, which are qualitative 
and semi-quantitative methods.4,5,8 For culture 
using qualitative method, the tip of catheter is 
aseptically  removed and immersed in liquid 
medium and then the procedure of growing 
in blood agar is carried out and the culture 
is incubated for 24 hours at 370C. The semi-
quantitative method includes rolling the tip of 
catheter (with ±5 cm length) on the surface of 
blood agar plate, the culture was incubated for 
24 hours at 370C and the number of growing 
colonies was counted.3-5
According to one of criteria issued in the 
CDC’s National Healthcare Safety Network 
(CDC’s NHSN) for CR-BSI as quoted from 
the Association for Professionals in Infection 
Control (APIC),4 CR-BSI is defined when 
the result of culture through catheter tip is 
semiquantitatively positive (>15 CFU/tip), which 
is known as  positive CR-BSI. Semi-quantitative 
method for culture of catheter tip has been more 
recommended by the CDC’s NHSN than the 
qualitative method; however, the qualitative 
method has also been used widely until now.4,8 
A study by Marconi9 comparing qualitative 
and semi-quantitative method for cultures has 
found 100% sensitivity and 60% specificity for 
qualitative method; while 90% sensitivity and 
71% specificity for semi-quantitative method. A 
study conducted by Safdar as quoted by Marconi 
has demonstrated 90% sensitivity and 72% 
specificity for qualitative method; while for semi-
quantitative method, the study has shown 85% 
sensitivity and 82% specificity. Cultures using 
semi-quantitative method have demonstrated 
higher specificity than qualitative method with 
cut-off point of >15 CFU/tip, which can reduce 
the possibility of false positive result.9
In the present case, the patient came for 
routine dialysis session and during the HD 
procedure, he had suffered clinical symptoms 
of fever and shivering (pulse rate 110 beats per 
minute and body temperature of 38.5 0C) within 
several hours after having HD and he also had 
inflammatory signs at the site of CDL insertion. 
The chest radiography revealed that his heart 
and lungs were within normal limits. The HD 
procedure was stopped, double lumen catheter / 
CDL was removed, a diagnosis of CKD on HD + 
suspected CR-BSI was made and the patient was 
immediately hospitalized. CDL had been inserted 
since the patient had routine HD, i.e. within 
the last 2 months prior to hospitalization. The 
double lumen catheter (CDL) was inserted on the 
internal jugular vein (central vein) according to 
the non-tunneled CVCs technique for < 3 months 
insertion (short term). There was no history of 
fever and shivering during the previous routine 
HD session.
In this patient, we found identical results 
between culture withdrawn through the tip 
of catheter lumen and peripheral blood as 
well as identical results of antimicrobial 
resistance testing, which is in consistent with the 
IDSA criteria guideline for CR-BSI diagnosis. 
According to the guideline, diagnosis of CR-BSI 
is made when there are no bacteria in blood, 
there is clinical and laboratory indication of 
infection, no clear source of infection other than 
the CDL and positive culture reveal identical 
microorganism between blood culture and 
culture through CDL. Definitive diagnosis of 
CR-BSI is established when during the CVC/
CDL insertion there is signs of infection on 
the insertion site, there is clinical symptoms of 
bacteremia or sepsis, the clinical signs resolved 
and diminished following the removal of CVC/
CDL, results on type of microorganism between 
culture withdrawn through the tip of catheter 
lumen and peripheral blood are identical, no 
other source of infection has been found to cause 
bacteriemia other than the CVC/CDL (primary 
bacteremia).3, I0 Among those criteria, the most 
important gold standard for establishing the 
diagnosis of CR-BSI is when results between 
culture withdrawn through the tip of catheter 
lumen and peripheral blood at the same time are 
identical.2-4,8
In the present case, we found several 
evidences which pointed out to the possibility 
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that CR-BSI has occurred, i.e. on history taking, 
the patient had fever and shivering during HD 
procedure, which diminished immediately 
after the catheter was removed. On physical 
examination, there were signs of phlebitis on 
the exit site of the CDL, no other source of 
infection was found other than catheter and the 
results between culture withdrawn through the 
tip of catheter lumen and peripheral blood were 
identical, which is the diagnostic gold standard 
for CR-BSI. Therefore, the data of our patient 
has fulfilled the diagnosis criteria for CR-BSI. 
Accurate diagnosis of CR-BSI is extremely 
important and needed for effective and prompt 
management such as removing catheter as it 
may serve the source of infection and therefore, 
more serious complications can be avoided for 
the patient’s sake.2,10
CDL insertion must consider some issues, 
i.e. catheter must be inserted using aseptic 
technique and must be removed immediately 
when it is no longer necessary or if it is suspected 
leading to sepsis. Catheter that has been inserted 
through jugular and subclavian veins must not 
be removed on a routine base and when it must 
be continued for longer use, gauze dressing for 
catheter must be checked and replaced every 
48-72 hours.6 When performing CVC/CDL 
insertion, in addition to aseptic procedure, a good 
and appropriate hand hygiene must be carried 
out as well as using gloves and mask to prevent 
and reduce the incidence of infection. The use 
of skin antiseptic such as povidone iodine or 
2% chlorhexidine gluconate prior to CVC/CDL 
insertion may reduce the incidence of CR-BSI. 
Overall, the strategy of preventing CR-BSI 
includes measures of providing education for 
patients and health care providers who perform 
CVC/CDL insertion, the use of antibiotic lock or 
heparin lock on CVC/CDL insertion, applying 
the procedure of appropriate aseptic technique, 
the use 2% chlorhexidine gluconate for skin 
antiseptic when performing CVC insertion as 
well as checking and replacing dressing for CVC/
CDL once in every three days before and after 
HD procedure has been carried out.3,9,11
The incidence of CR-BSI, as quoted by 
Fletcher,3 varies between 3 and 16 % depending 
on risk factors and types of the inserted catheter. 
The rate of CR-BSI incidence depends on 
different site and duration of catheter placement, 
types of catheter material that has been used, 
potency of contamination at the exit site or hub, 
CVC/CDL insertion technique and risk factors 
for infection in the patients themselves.7
The lowest incidence of infection has been 
found when CVC/CDL is inserted through 
subclavian vein followed by internal jugular vein 
as the insertion site and the highest incidence 
of CR-BSI is found when the femoral vein is 
used as the insertion site. Regarding the catheter 
material, polyurethane or silicone catheters are 
good enough; however, further studies need to 
be done on selecting the best catheter material to 
prevent the development of CR-BSI.3
According to the 2012 Kidney Disease 
Improving Global Outcomes (KDIGO) criteria,12 
CKD patients with creatinine clearance of <15 
are categorized into patients with renal failure 
or End State Renal Disease who require HD 
procedure. In CKD patients who are on HD 
with insertion of CVC/CDL, there is a risk 
of developing CR-BSI.12 In addition to CVC/
CDL insertion, catheter caring and duration of 
CVC/CDL insertion may also have a risk for 
developing infection. Some other risk factors that 
may have roles on the development of CR-BSI 
in patients with hemodialysis are elderly age, 
comorbidities of CKD such as diabetes mellitus, 
malignancy, hypoalbuminemia and anemia. 
In patients with diabetes mellitus and CKD, 
there can be some abnormalities of immune 
system, which can be aggravated by uremia 
that may facilitate the development of infection. 
Hypoalbuminemia may also exacerbate immune 
defect in CKD patients.1,13
Actually, the most common cause and 
microorganism that allows colonization or 
phlebitis on the site is Staphylococcus sp. 
such as S. epidermidis or S.aureus. The most 
common bacteria causing CR-BSI in HD patients 
are Gram-positive cocci (52 to 70%) such as 
S.aureus and S.epidermidis. Gram-negative 
bacteria are found as etiologies in about 24 to 
26.7% cases.13 (Table 2)
Microorganism causing CR-BSI can enter 
bloodstream thorugh several mechanisms and 
the first is through direct migration from skin 
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surface, i.e. from the outer surface of catheter to 
catheter tip at the location of catheter insertion 
(extraluminal), which is usually associated with 
bacteria colonization on the skin surface.
The second mechanism is through catheter 
hub, which is contaminated during HD procedure 
is performed; while the third mechanism 
is through contamination of dialysis fluid 
(intraluminal). Bacteria on skin surface near 
the location of catheter insertion can migrate 
through catheter reaching the catheter tip and 
finally entering bloodstream and spread through 
catheter lumen.3,13 When the catheter is inserted, 
the exit site of the catheter will be immediately 
covered by serum protein such as fibrinogen, 
fibronectin, laminin and collagen that cover 
the outer surface of intravenous catheter. The 
protein layers along with glycocalix (slime) 
produced by the bacteria will develop a biofilm, 
which become the site of bacterial attachment, 
replication and colonization.3
In the present case, we found a different type 
of microorganism, i.e. the E. cloacae, which is 
a Gram-negative rod bacteria and it is included 
in the Enterobacteriaceae family. The free-living 
bacteria are found in gastrointestinal tract, septic 
tank, river water and plants. They have optimum 
growth at 370C and they are facultative anaerobs, 
oxidase negative and katalase positive. The 
bacteria can cause nosocomial infection in the 
hospital and resulting in bacteremia, skin and 
soft tissue infection and urinary tract infection. 
Moreover, the bacteria can also produce beta 
laktamase and they easily become resistant to 
the third and fourth generation of cephalosporin 
or become Multiple Drug Resistant Organism 
(MDRO). Transmission of infection or outbreaks 
may occur through contaminated hands of the 
health-care workers, contaminated medical 
equipment or water. E. cloacae found in the 
present case was probably caught by the patient 
when he had a bath/cleaned himself in the public 
toilet at the HD department in the hospital and 
used water contained in water basin (tile tub) next 
to the toilet that might have been contaminated, 
which subsequently caused phlebitis at the 
exit site of CDL and then the bacteria entered 
the bloodstream when the HD procedure was 
performed.
In the present case, although the wound 
dressing at the exit site has been checked and 
replaced each time the patient had a controlled 
visit for HD session twice a week, but waterproof 
occlusive dressing had not been used and 
therefore, it had a high potency for contamination. 
There are some ways for microorganism entering 
bloodstream, which are through contaminated 
dialysis fluid or through contaminated hub or 
through colonization at the exit site and the 
microorganism enters bloodstream during the 
HD procedure.
Unfortunately, no culture had been done 
based on samples from dialysis fluid in the 
present case; however, the most recent data on 
culture of dialysis fluid, which is performed 
every 3 months, shows that the dialysis fluid is 
still useable and there was no other case of CR-
BSI found in other patients who also had used 
the dialysis fluid. Based on findings of phlebitis 
signs and the development of fever within 4 
hours following the HD procedure, there is a 
great possibility that the microorganism was 
caught through the exit site of CDL, which 
might have formed colonization at the exit 
site and entered the bloodstream during the 
HD procedure. Education for patient is also 
necessary, particularly on CDL care when the 
catheter has been removed and replaced by a 
new CDL so that the catheter is always in a clean 
and dry condition without any contamination to 
avoid colonization or infection at the exit site of 
CDL. Providing antibiotics such as i cefazolin, 
gentamicin (antibiotic lock), heparin (heparin 
Table 3. Profile of bacteria causing CR-BSI13
Gram positive cocci 52-70%
S. aureus 21.9-60%
S. epidermidis 8.8-12.6%
MRSA** 6.0-8.0%
Enterococcus faecalis 2.4-8.0%
Gram negative bacilli 24-26.7%
Pseudomonas aeruginosa 2.3-15.2%
Escherichia coli 10.4%
Acinetobacter spp. 12.8%
Serratia marcesens 1.2-2.3%
Klebsiella pneumoniae 6.4%
Enterobacter doacae 8.8%
Polymicrobial 16.2-20%
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lock) into catheter lumen and skin antiseptics 
(chlorhexidine) will reduce the migration of 
microorganism from the intracutaneous to 
intravascular segment of the catheter.10,12,13 
Heparin lock was administered at the dose of 
1.5 mL/ 7500 U heparin into the catheter lumen 
following the HD procedure, which has a role 
to prevent blood clot that may develop into 
septic thrombophlebitis. The heparin lock can be 
administered simultaneously with antibiotic lock. 
The antibiotic lock is usually given for long-term 
CDL for 7-14 days and it should not be given 
on a routine basis as may induce antimicrobial 
resistance. If bacteremia or sepsis has developed, 
clinical symptoms such as shivering, fever or 
even hypotension and shock may occur.14
Antibiotics that are quite effective for the 
bacteria are aminoglycosides, cefotaxime and 
cefoperazone.15 Antibiotic treatment should be 
based on results of culture and antimicrobial 
resistance test.3,11 Empiric treatment for 
Gram-negative bacteria depends on pattern 
of microorganism and the severity of disease. 
Usually, the fourth generation of cephalosporin, 
carbapenem, combined treatment of beta 
lactam and aminoglycosides are administered. 
Vancomycin can be given as empiric treatment 
whenever the presence of Methicillin Resistant 
Staphylococcus Aureus (MRSA) is suspected. 
Definitive antibiotic treatment for CR-BSI is 
usually given for 7 to 10 days; while for CR-BSI 
cases with complications, the antibiotic can be 
given up to 2 weeks.11,14,16
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Complete
Data
More
Appropriate
More
Effective
Less
Toxic Alternatives
Cheaper
Alternatives
Narrower
Spectrum Alternatives
Duration
is too long
Duration
is too short
No
No
Yes
Yes
Yes
Yes
No
Yes
Yes
No
No
No
No
Yes
IIIa IIIb
IVd
IVc
IVb
IVa
V
VI
Appropriate
Dose
Appropriate
Interval
Appropriate
Route
Appropriate
Timing
No
No
No
No
No
Yes
Yes
Yes
Yes
I
IIc
IIb
IIa
The algorithm stops at III B
(duration too short)
Yes
Stop
Stop
0   =   (APPROPRIATE)
Figure 1. Gyssens algorithm for evaluating the use of meropenem
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Empiric treatment using ceftriaxone for 3 
days in the present case obviously did not bring 
any significant clinical improvement as the 
patient was still having fever and the leukocyte 
count was increasing. After receiving the result 
of blood culture and culture of the CDL tip, 
we knew that the microorganism was indeed 
resistant to ceftriaxone.
Based on the results of antimicrobial 
resistance testing, blood culture and culture 
of the CDL tip, the antibiotic treatment was 
then replaced by meropenem. The meropenem 
treatment was provided after the result of blood 
culture and CDL tip had been known and it was 
obvious that there was identical microorganism 
between both cultures, which is consistent with 
the diagnosis criteria of CR-BSI. Afterwards, 
there was clinical improvement and the patient 
was discharged from the hospital without any 
oral antibiotics.
When evaluating the use of meropenem 
with Gyssen algorithm (Figure 1), we found 
that the data of medical records was complete, 
the indication for definitive treatment was 
appropriate, the antibiotic given had a narrow 
spectrum, inexpensive, safe and the most 
effective against E. cloacae; however, the 
duration of treatment was too short (less than 
5 days); in contrast, the recommended duration 
of antibiotic treatment for CR-BSI should be at 
least 7 days; therefore, the evaluation for the used 
Meropenem using Gyssen algorithm stopped 
at the III B, i.e. in the category of duration of 
treatment was too short.
CONCLUSION
Whenever there is a sudden fever during 
hemodialysis procedure, the possibility of 
developing Catheter Related Blood Stream 
Infections (CR-BSI) should be considered. 
We found that results of culture withdrawn 
through the tip of catheter lumen and peripheral 
blood revealed identical microorganism, i.e. 
Enterobacter  cloacae, which supports the 
diagnosis of CR-BSI. Overall, prevention 
measures for CR-BSI should be taken into account 
including education for patient, awareness of 
the health care providers who install the CDL, 
implementation of procedure for appropriate 
skin aseptic technique and best practice for HD 
catheter care, particularly on the exit site of the 
CDL to prevent the development of CR-BSI.
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